Hepatorrenal syndrome in acute on chronic hepatic failure: about a case
PDF (Español (España))
XML (Español (España))

Keywords

Cirrhosis, Hepatic failure, Hepatic encephalopathy, Hepatorenal syndrome, Liver transplantation.

How to Cite

1.
Giraldo Ocampo CC, Jiménez Bejarano MF, Torres Saltarin JJ. Hepatorrenal syndrome in acute on chronic hepatic failure: about a case. Rev. Colomb. Nefrol. [Internet]. 2021 Mar. 23 [cited 2022 Aug. 11];8(2):e532. Available from: https://revistanefrologia.org/index.php/rcn/article/view/532

Abstract

Acute-on-chronic liver failure (ACLF) is a recently characterized entity and presents as an acute decompensation of chronic liver disease, it can be associated with failure in different organs and present high mortality. Its incidence reaches up to 30% of patients who consult for complications in base cirrhosis.

Among the most frequent precipitating factors are bacterial infections, alcoholism and reactivation of viral hepatitis, but, in up to 40% of cases, no precipitating factor is identified. The pathophysiology of this entity is still unknown to a certain extent, but the existence of an excessive inflammatory response in its development is suggested.

There is no specific treatment and its management is based on treatment for associated complications, support, and finally liver transplantation.

Kidney dysfunction is a common finding in patients with liver disease. Hepatorenal syndrome, which was thought to be purely functional in nature and now, given the evidence of some degree of related tubular damage, the understanding of the pathophysiology of this entity has improved and has recently forced a rethink of the diagnostic criteria and the classification of the illness.

We describe the clinical case of a patient treated at a hospital in the city of Pereira, Risaralda. who presented bacteremia due to gram-positive cocci, of unclear origin, this was considered as the precipitating factor, had clinical deterioration, with the appearance of hepatorenal syndrome and multi-organ failure, finally leading to death despite multidisciplinary management.

https://doi.org/10.22265/acnef.8.2.532
PDF (Español (España))
XML (Español (España))

References

1. Jalan, R., Gines, P., Olson, J. C., Mookerjee, R. P., Moreau, R., Garcia-Tsao, G., ... & Kamath, P. S. (2012). Acute-on chronic liver failure. Journal of hepatology, 57(6), 1336-1348.
2. Sarin, S. K., Kumar, A., Almeida, J. A., Chawla, Y. K., Fan, S. T., Garg, H., ... & Lau, G. K. (2009). Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatology international, 3(1), 269.
3. Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., ... & Gerbes, A. (2013). Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology, 144(7), 1426-1437.
4. Solé, C., & Solà, E. (2018). Actualización en la insuficiencia hepática aguda sobre crónica. Gastroenterología y Hepatología, 41(1), 43-53.
6. Licata, A., Maida, M., Bonaccorso, A., Macaluso, F. S., Cappello, M., Craxì, A., & Almasio, P. L. (2013). Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World journal of hepatology, 5(12), 685.
7. Mookerjee, R. P., Stadlbauer, V., Lidder, S., Wright, G. A., Hodges, S. J., Davies, N. A., & Jalan, R. (2007). Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology, 46(3), 831-840.
8. Mookerjee, R. P. (2011). Acute-on-chronic liver failure: the liver and portal haemodynamics. Current opinion in critical care, 17(2), 170-176.
9. Rolando, N., Wade, J. I. M., Davalos, M., Wendon, J., Philpott-Howard, J., & Williams, R. (2000). The systemic inflammatory response syndrome in acute liver failure. Hepatology, 32(4), 734-739.
10. González-Regueiro, J. A., Higuera-de la Tijera, M. F., Moreno-Alcántar, R., & Torre, A. (2019). Fisiopatología y opciones de tratamiento a futuro en la encefalopatía hepática. Revista de Gastroenterología de México.
11. Kandiah, P. A., & Kumar, G. (2016). Hepatic encephalopathy—the old and the new. Critical care clinics, 32(3), 311-329.
12. Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., & Blei, A. T. (2002). Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35(3), 716-721.
13. Garza, L. C. (2005). Diálisis con albúmina mediante MARS. Principios y técnicas. Experiencia inicial en México. Gastroenterología y hepatología, 28(2), 85-94.
14. Kobashi-Margáin, R. A., Gavilanes-Espinar, J. G., Gutiérrez-Grobe, Y., Gutiérrez-Jiménez, Á. A., Chávez-Tapia, N., Ponciano-Rodríguez, G., ... & Méndez Sánchez, N. (2016). Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure. Annals of hepatology, 10(S2), 70-76.
15. Arvaniti, V., D'Amico, G., Fede, G., Manousou, P., Tsochatzis, E., Pleguezuelo, M., & Burroughs, A. K. (2010). Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology, 139(4), 1246-1256.
16. Merino, G. A. (2010). Evaluación de los sistemas de soporte hepático extracorpóreo en el tratamiento de la insuficiencia hepática. Revisión sistemática. Gastroenterología y hepatología, 33(5), 352-362.
17. Ospina, J. R., & Restrepo, J. C. (2017). Síndrome hepatorrenal: fisiopatología, diagnóstico y manejo. Revista Colombiana de Gastroenterología, 31(2), 146-153.
18. Ginès, P., & Schrier, R. W. (2009). Renal failure in cirrhosis. New England Journal of Medicine, 361(13), 1279-1290.
19. Angeli, P., Ginès, P., Wong, F., Bernardi, M., Boyer, T. D., Gerbes, A., ... & Moore, K. (2015). Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut, 64(4), 531-537.
20. Acevedo, J. G., & Cramp, M. E. (2017). Hepatorenal syndrome: Update on diagnosis and therapy. World journal of hepatology, 9(6), 293.
21. Salerno, F., Gerbes, A., Ginès, P., Wong, F., & Arroyo, V. (2007). Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut, 56(9), 1310-1318.
22. Ginès, P., & Solà, E. (2012). síndrome hepatorrenal. Nefrología (English Edition), 7(1), 0.
23. European Association For The Study Of The Liver. (2010). EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology, 53(3), 397.
24. Fagundes, C., & Ginès, P. (2012). Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. American Journal of Kidney Diseases, 59(6), 874-885.
25. Sanyal, A. J., Boyer, T., Garcia–Tsao, G., Regenstein, F., Rossaro, L., Appenrodt, B., ... & Terlipressin Study Group. (2008). A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology, 134(5), 1360-1368.
26. Testino, G. (2017). Hepatorenal syndrome: role of the transjugular intrahepatic stent shunt in real life practice. Clujul Medical, 90(4), 464.
27. Eason, J. D., Gonwa, T. A., Davis, C. L., Sung, R. S., Gerber, D., & Bloom, R. D. (2008). Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). American Journal of Transplantation, 8(11), 2243-2251.
28. Tujios, S. R., Hynan, L. S., Vazquez, M. A., Larson, A. M., Seremba, E., Sanders, C. M., ... & Acute Liver Failure Study Group. (2015). Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clinical Gastroenterology and Hepatology, 13(2), 352-359.
29. Salerno, F., Gerbes, A., Ginès, P., Wong, F., & Arroyo, V. (2007). Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut, 56(9), 1310-1318.
30. Sayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016). Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clinics in liver disease, 20(2), 205-214.
31. Angeli, P., Garcia-Tsao, G., Nadim, M. K., & Parikh, C. R. (2019). News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. Journal of hepatology, 71(4), 811-822.
32. European Association for the Study of the Liver. (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of hepatology, 69(2), 406-460.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2021 Revista Colombiana de Nefrología

Dimensions


PlumX


Downloads

Download data is not yet available.